La información proporcionada en EL7.AI es solo con fines educativos e informativos y no constituye asesoramiento financiero.

Última horastocks

Ascendis Pharma Reports Positive Two-Year Data for Achondroplasia Treatment

Detectado por primera vez: Mar 16, 2026, 12:19 PM

Última actualización: 10 days ago

21 artículos·21 historias

Instrumentos afectados

ASND

Resumen del evento

Ascendis Pharma reported positive two-year data for achondroplasia treatment. Data from the ApproaCH trial, announced on March 16, showed consistent growth improvement in children with achondroplasia using TransCon CNP. Further improvement in body proportionality was observed during the second year of weekly treatment.